Opko Health, Inc.
OPK US68375N1037
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Krasno Richard M |
0.99 USD |
30,000 Bought |
29,838 USD |
29/01/2024 | 29/01/2024 |
| Hsiao Jane Ph D CB |
0.95 USD |
150,000 Bought |
142,500 USD |
17/01/2024 | 17/01/2024 |
| Nabel Gary J. CInO |
0.93 USD |
108,695 Bought |
100,543 USD |
08/01/2024 | 08/01/2024 |
| Nabel Gary J. CInO |
0.93 USD |
106,989 Bought |
99,425 USD |
08/01/2024 | 08/01/2024 |
| Nabel Gary J. CInO |
0.92 USD |
500 Bought |
459 USD |
08/01/2024 | 08/01/2024 |
| Zerhouni Elias A. CB |
0.94 USD |
400,000 Bought |
376,000 USD |
05/01/2024 | 05/01/2024 |
| Rubin Steven D EX VP |
0.87 USD |
10,000 Bought |
8,669 USD |
05/01/2024 | 05/01/2024 |
| Hsiao Jane Ph D CB |
0.87 USD |
150,010 Bought |
130,899 USD |
04/01/2024 | 05/01/2024 |
| Zerhouni Elias A. CB |
0.93 USD |
100,000 Bought |
93,000 USD |
05/01/2024 | 05/01/2024 |
| Pfenniger Richard C Jr |
0.93 USD |
13,000 Bought |
12,043 USD |
05/01/2024 | 05/01/2024 |